1. All options
  2. Medications

Antidepressants used for pain

Some antidepressants, especially duloxetine, can turn down long-lasting pain signals, though the average benefit for back pain is small.

Also called: SNRI, duloxetine, Cymbalta, amitriptyline, nortriptyline, tricyclics

Warning signs: when to get urgent care

At a glance

What it is used for
Some antidepressants, especially duloxetine, are used for long-lasting pain, whether or not a person has depression. Most spine-pain research concerns the low back.
What research suggests
Duloxetine gives small average improvements in long-lasting back pain and function. Evidence for most other antidepressants, sciatica and neck-related arm pain is uncertain or very limited; guidelines differ. [2] [3] [4] [9] [15]
Main trade-offs
Nausea, dizziness and other side effects are common. Medicine interactions and mood changes need attention, and stopping suddenly can cause symptoms.

What it is

Some antidepressants can also ease certain kinds of long-lasting (chronic) pain. Two groups are used most for back and neck pain: SNRIs (serotonin and norepinephrine reuptake inhibitors) and older medicines called tricyclic antidepressants.

Duloxetine (Cymbalta) is the SNRI studied most for pain. The FDA has approved it for chronic musculoskeletal pain, including chronic low back pain. Venlafaxine (Effexor XR), another SNRI, is sometimes used for pain “off-label,” meaning without FDA approval for that use.

Tricyclics such as amitriptyline and nortriptyline (Pamelor) are also used off-label for pain.

Being offered an antidepressant for pain does not mean anyone thinks your pain is imagined, or that you must be depressed. These medicines are used because they act on the body’s pain system.

Most of the research is on low back pain. Very few studies have looked at neck pain.

How it helps

The brain and spinal cord have their own system for turning pain signals down, using chemical messengers such as serotonin and norepinephrine. Researchers think these medicines strengthen that system by raising those messengers, though much of what is known comes from animal studies.

The effect on pain seems to be largely separate from any effect on mood. In studies, people with depression did not get more pain relief than people without it.

For tricyclics, the doses used for pain are usually lower than the doses used for depression. Duloxetine is also approved to treat depression and anxiety, which some people live with alongside pain.

What to expect

Starting

Your prescriber will ask about your other medicines, alcohol use, liver and kidney health, blood pressure, heart health, glaucoma, seizures, and any personal or family history of bipolar disorder.

Doses usually start low and go up slowly, to give your body time to adjust.

Some people notice a change within a couple of weeks, but judging the full effect usually takes several weeks.

While you take it

Nausea is the most common side effect of duloxetine. Starting low and going up slowly helps many people adjust. Tricyclics often cause drowsiness, which is one reason they are usually taken in the evening. Until you know how the medicine affects you, take extra care with driving or other tasks that need you to be alert.

Stopping

Stopping suddenly can cause discontinuation symptoms, such as dizziness, nausea, headache, irritability, tingling and nightmares. They are usually mild. One review estimated that, after allowing for symptoms people also get when stopping a placebo, about 1 in 6 or 7 people who stop get symptoms caused by stopping. Results varied a lot between studies, and a few people have severe symptoms. Some medicines, such as venlafaxine, cause them more often. Prescribers usually lower the dose gradually.

How well it works

For long-lasting back pain, a large review found that SNRIs such as duloxetine lowered pain by about 5 points on a 0 to 100 scale over 3 months or less. That is a small effect, below what most people would notice. Daily function improved by a similarly small amount. [2]

An earlier review for the American College of Physicians also found modest benefits from duloxetine. Its guideline lists duloxetine as a second-line option for chronic low back pain, after nondrug treatments and anti-inflammatory pain relievers (NSAIDs). Guidelines in the US and UK disagree about using SNRIs for back pain.

Across many kinds of chronic pain, duloxetine has the most reliable evidence of any antidepressant. For most others, the evidence is uncertain. [4]

In combined studies, tricyclics did not clearly reduce back pain. One trial of low-dose amitriptyline for chronic low back pain found no clear pain benefit at 3 or 6 months, and only a small, short-lived gain in function. [2] [9]

Other antidepressants, such as sertraline (Zoloft) or fluoxetine (Prozac), have not helped back pain in the few studies done. [2] [7]

For sciatica, the evidence is too uncertain to say. A few small studies suggest tricyclics or SNRIs might help, but the results are not reliable. For pain down the arm from an irritated nerve in the neck, there is very little good research. [2] [15]

Little research has followed people for longer than 3 months. Averages hide a range. Some people get more relief than average and some get none, and studies cannot yet predict who will benefit.

Risks and downsides

Common with SNRIs

  • Nausea, dry mouth, constipation or diarrhea.
  • Sleepiness or trouble sleeping, tiredness and dizziness.
  • Sweating.
  • Sexual side effects, such as lower desire or trouble reaching orgasm.

In back pain and arthritis trials, about 6 in 10 people taking an SNRI had at least one side effect, compared with about 5 in 10 taking a placebo (dummy pill). About 1 in 8 stopped because of side effects, compared with about 1 in 20 on placebo.

Common with tricyclics

  • Dry mouth, constipation, blurred vision and trouble passing urine.
  • Drowsiness, and dizziness or light-headedness when standing up.

Less common

  • Higher blood pressure with SNRIs, more so with venlafaxine at higher doses. Your clinician may check it.
  • Easier bruising or bleeding with SNRIs, especially when combined with NSAIDs such as ibuprofen or naproxen, aspirin, or blood thinners.
  • Low blood sodium, mainly in older adults and people who take water pills. It can cause headache, confusion, weakness and unsteadiness.

Rare but serious

  • Suicidal thoughts. All antidepressants carry a boxed warning, the FDA’s strongest, about a higher risk of suicidal thoughts and behavior in children, teens and young adults under 25, especially when starting or changing the dose. In adults 25 and older, a large FDA review did not find this increase, and in people 65 and older the risk appeared lower.
  • Serotonin syndrome, a rare but dangerous reaction that can happen when these medicines are combined with others that raise serotonin. Examples include tramadol (Ultram) and some other opioids, other antidepressants, the muscle relaxant cyclobenzaprine, migraine medicines called triptans, the cough medicine dextromethorphan, and St. John’s wort. They must not be combined with MAO inhibitors, a group that includes the antibiotic linezolid and some Parkinson’s medicines. Signs include agitation or confusion, a fast heartbeat, sweating, fever, and muscle twitching or stiffness.
  • Liver injury is rare with duloxetine. It is usually not prescribed for people who drink alcohol heavily or have chronic liver disease.
  • Tricyclics are far more dangerous in overdose than newer antidepressants, mainly because of heart rhythm problems, so prescribers take extra care when there is any risk of self-harm.

Older adults

Older adults taking any antidepressant have a higher risk of falls, especially alongside other medicines that cause drowsiness. Guidance for older adults advises avoiding amitriptyline and nortriptyline, because they can cause confusion, drowsiness and dizziness on standing.

Other downsides

  • The average benefit for back pain is small, while side effects are common.

Get emergency care right away for thoughts of harming yourself, fainting, a very fast or irregular heartbeat, or signs of serotonin syndrome such as high fever, stiffness and confusion. In the US you can also call or text 988, the Suicide and Crisis Lifeline. Contact your clinician right away about worsening mood, new agitation or restlessness, or unusual changes in behavior. Call the same day about yellow skin or eyes, dark urine, or unusual bruising or bleeding.

Talk to your clinician about

  • Why an antidepressant for my pain, and what do we hope it will do?
  • How long before we can tell if it is working?
  • Is it safe with my other medicines, such as tramadol, migraine medicines, other antidepressants, NSAIDs or blood thinners?
  • Do my alcohol use, liver health, blood pressure or heart health affect which medicine fits best?
  • Which side effects should I expect early on, and which ones mean I should call you?
  • If I want to stop, how do we lower the dose safely?
  • I also feel low or anxious. Could this medicine help with that too?
  • I am pregnant, planning a pregnancy, or breastfeeding. Does that change the plan?
Print visit questions

This page is general education. It can’t weigh your history, your exam, or your scans, so it can’t say which choice fits your situation. Your own clinician can. The questions above are a good place to start that conversation.

More in medications

  • Acetaminophen

    A common pain and fever reliever that is easy on the stomach. Studies show it does little for low back pain, and too much can seriously harm the liver.

  • Anti-inflammatory pain relievers (NSAIDs)

    Medicines such as ibuprofen and naproxen that ease pain and inflammation. For low back pain they give a small, short-term benefit, and they carry stomach, kidney and heart risks.

  • Muscle relaxants

    Short-term prescription medicines for back or neck pain with muscle spasm, which on average help only a little and often cause drowsiness.

  • Gabapentin and pregabalin

    Nerve pain medicines that help some nerve conditions but have shown little or no benefit for most back pain and sciatica.

Sources

Numbered links connect selected research statements to these references. See the full guide for limitations and differences between guidelines.

  1. Cymbalta (duloxetine) delayed-release capsules. US prescribing information. Eli Lilly and Company.
  2. Ferreira GE, McLachlan AJ, Lin CC, et al. Efficacy and safety of antidepressants for the treatment of back pain and osteoarthritis: systematic review and meta-analysis. BMJ. 2021;372:m4825.
  3. Qaseem A, Wilt TJ, McLean RM, Forciea MA; Clinical Guidelines Committee of the American College of Physicians. Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2017;166(7):514-530.
  4. Birkinshaw H, Friedrich CM, Cole P, et al. Antidepressants for pain management in adults with chronic pain: a network meta-analysis. Cochrane Database Syst Rev. 2023;5(5):CD014682.
  5. Obata H. Analgesic mechanisms of antidepressants for neuropathic pain. Int J Mol Sci. 2017;18(11):2483.
  6. Ormseth MJ, Scholz BA, Boomershine CS. Duloxetine in the management of diabetic peripheral neuropathic pain. Patient Prefer Adherence. 2011;5:343-356.
  7. Chou R, Deyo R, Friedly J, et al. Systemic pharmacologic therapies for low back pain: a systematic review for an American College of Physicians clinical practice guideline. Ann Intern Med. 2017;166(7):480-492.
  8. Effexor XR (venlafaxine extended-release) capsules. US prescribing information, 2022.
  9. Urquhart DM, Wluka AE, van Tulder M, et al. Efficacy of low-dose amitriptyline for chronic low back pain: a randomized clinical trial. JAMA Intern Med. 2018;178(11):1474-1481.
  10. Amitriptyline hydrochloride tablets, USP. US prescribing information, 2025.
  11. Enomoto H, Fujikoshi S, Funai J, et al. Assessment of direct analgesic effect of duloxetine for chronic low back pain: post hoc path analysis of double-blind, placebo-controlled studies. J Pain Res. 2017;10:1357-1368.
  12. Hawton K, Bergen H, Simkin S, et al. Toxicity of antidepressants: rates of suicide relative to prescribing and non-fatal overdose. Br J Psychiatry. 2010;196(5):354-358.
  13. Skljarevski V, Desaiah D, Liu-Seifert H, et al. Efficacy and safety of duloxetine in patients with chronic low back pain. Spine (Phila Pa 1976). 2010;35(13):E578-E585.
  14. Henssler J, Schmidt Y, Schmidt U, Schwarzer G, Bschor T, Baethge C. Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis. Lancet Psychiatry. 2024;11(7):526-535.
  15. Peene L, Cohen SP, Brouwer B, et al. 2. Cervical radicular pain. Pain Pract. 2023;23(7):800-817.
  16. By the 2023 American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71(7):2052-2081.
  17. Thase ME. Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients. J Clin Psychiatry. 1998;59(10):502-508.
  18. Perahia DG, Bangs ME, Zhang Q, et al. The risk of bleeding with duloxetine treatment in patients who use nonsteroidal anti-inflammatory drugs (NSAIDs): analysis of placebo-controlled trials and post-marketing adverse event reports. Drug Healthc Patient Saf. 2013;5:211-219.
  19. Stone M, Laughren T, Jones ML, et al. Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. BMJ. 2009;339:b2880.
  20. Baldo BA. Opioid analgesic drugs and serotonin toxicity (syndrome): mechanisms, animal models, and links to clinical effects. Arch Toxicol. 2018;92(8):2457-2473.
  21. Orlova Y, Rizzoli P, Loder E. Association of coprescription of triptan antimigraine drugs and selective serotonin reuptake inhibitor or selective norepinephrine reuptake inhibitor antidepressants with serotonin syndrome. JAMA Neurol. 2018;75(5):566-572.
  22. Keegan MT, Brown DR, Rabinstein AA. Serotonin syndrome from the interaction of cyclobenzaprine with other serotoninergic drugs. Anesth Analg. 2006;103(6):1466-1468.
  23. Talarico G, Tosto G, Pietracupa S, et al. Serotonin toxicity: a short review of the literature and two case reports involving citalopram. Neurol Sci. 2011;32(3):507-509.
  24. Wernicke J, Acharya N, Strombom I, et al. Hepatic effects of duloxetine-II: spontaneous reports and epidemiology of hepatic events. Curr Drug Saf. 2008;3(2):143-153.
  25. Foianini A, Joseph Wiegand T, Benowitz N. What is the role of lidocaine or phenytoin in tricyclic antidepressant-induced cardiotoxicity? Clin Toxicol (Phila). 2010;48(4):325-330.
  26. 988 Suicide & Crisis Lifeline. About 988. Substance Abuse and Mental Health Services Administration.
Back to all options